Filter
56
Filtered Results: 56
Text search:
W.
Ameyan
Featured
Recommendations
2
New Publications
1
Language
Document type
Studies & Reports
27
Guidelines
13
No document type
8
Fact sheets
4
Manuals
2
Training Material
1
Strategic & Response Plan
1
Countries / Regions
Global
3
Kenya
2
India
2
Ukraine
1
Benin
1
Sierra Leone
1
Rwanda
1
Syria
1
Burkina Faso
1
Malawi
1
Mozambique
1
Haiti
1
Guinea-Bissau
1
Bangladesh
1
South Africa
1
Uganda
1
Angola
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
11
Public Health
3
Clinical Guidelines
2
Capacity Building
1
Women & Child Health
1
Key Resources
1
Toolboxes
HIV
10
COVID-19
7
Planetary Health
6
AMR
5
Mental Health
4
NCDs
4
Refugee
3
Caregiver
3
Disability
2
Social Ethics
2
NTDs
2
Rapid Response
1
Natural Hazards
1
Pharmacy
1
Global Health Education
1
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Almost half (46%) of the world’s 1.7 million children living with HIV were not on treatment in 2020 and 150 000 children were newly infected with HIV, four times more than the 2020 target of 40 000
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
Pregnancy and childbirth during adolescence profoundly affects the lives of millions of girls worldwide, and is a leading cause of maternal mortality and morbidity, and infant and child mortality. Every year, an estimated 21 million girls aged 15–19 years old in low- and middle-income countries be...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Adolescence is a critical stage in life for physical, cognitive and emotional development, shaping future health and well-being. Comprehensive measurement of adolescent health is essential to prioritize health issues, guide interventions and track progress. However, global, regional and national ado...
These guidelines provide recommendations for the non-pharmacological aspects of infection prevention and control for acute respiratory diseases (ARD) in health care. Administrative and infection controls, including early detection, isolation and reporting, and establishment of infection control infr...
Recognition, Assessment and Treatment
National Clinical Guideline Number 159
Politique Nationale de Promotion de la Santé, Version Finale
Experiences from Indonesia, Kenya, Uganda and Ukraine
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug...
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
Uso racional de equipamentos de proteção individual para a doença causada pelo coronavírus 2019 (COVID-19)
recommended
Orientação provisória, 6 de abril de 2020
Este documento resume as recomendações da OMS para o uso racional de equipamentos de proteção individual (EPIs) em unidades de saúde e na assistência domiciliar, bem como no manuseio de cargas; avalia também a situação atual da cadeia de abastec...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
